On Invalid Date, Bausch Health Companies (NYSE: BHC) reported Q2 2024 earnings per share (EPS) of $0.03, up 57.14% year over year. Total Bausch Health Companies earnings for the quarter were $10.00 million. In the same quarter last year, Bausch Health Companies's earnings per share (EPS) was $0.07.
As of Q3 2024, Bausch Health Companies's earnings has grown year over year. Bausch Health Companies's earnings in the past year totalled -$471.00 million.
What is BHC's earnings date?
Bausch Health Companies's earnings date is Invalid Date. Add BHC to your watchlist to be reminded of BHC's next earnings announcement.
What was BHC's revenue last quarter?
On Invalid Date, Bausch Health Companies (NYSE: BHC) reported Q2 2024 revenue of $2.40 billion up 10.89% year over year. In the same quarter last year, Bausch Health Companies's revenue was $2.17 billion.
What was BHC's revenue growth in the past year?
As of Q3 2024, Bausch Health Companies's revenue has grown 10.2% year over year. This is 25.83 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 36.04%. Bausch Health Companies's revenue in the past year totalled $9.20 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.